PLPEPTILENSEvidence-first peptide profiles

CURATED RESEARCH ATLAS

The evidence-first peptide research atlas.

Explore mechanisms, clinical evidence, safety context, regulatory status, and source-linked summaries for peptide medicines and research compounds.

147
Peptides
63
Approved
441
Claims
147
Studies
63 matching entriesReset

Evidence-graded

Claim records carry source quality labels.

Source-linked

FDA labels, PubMed papers, and compound records.

Safety-aware

Warnings are separated from benefit claims.

Educational only

No protocols, vendors, or self-use instructions.

INTERACTIVE EXPLORER

Start with the question you actually have.

Peptide research gets confusing fast because approvals, animal studies, supplement claims, cosmetic claims, and research-use-only materials often get mixed together. These paths keep those categories separated while you explore.

PEPTIDES IN PLAIN ENGLISH

Small signals, big context.

A peptide is a short chain of amino acids. Some peptides are prescription medicines, some are natural human hormones, some are cosmetic or supplement ingredients, and some are research chemicals with no approved human-use pathway.

What they do

Peptides can act like messages. They may bind receptors, trigger hormone pathways, or influence local tissue signals.

Why evidence matters

A claim from an FDA label is very different from an animal study, a cosmetic claim, or a marketing claim.

Why status matters

Approved, compounded, listed, supplement, cosmetic, and research-use-only are different categories with different risks.

ENCYCLOPEDIA

Peptide profiles

Each profile opens into an evidence page with claims, safety context, regulatory status, and source cards.

Abaloparatide

Fda Label

Tymlos

Approved

Abaloparatide is classified as Parathyroid hormone-related peptide analog. This profile separates what is known from source-linked evidence, what remains uncertain, safety considerations, and the US regulatory context.

Product category
FDA-approved peptide drug or regulated peptide/hormone medication
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 6 sources

Open profile

Angiotensin II

Fda Label

Giapreza

Approved

Angiotensin II is classified as Vasoactive peptide hormone. This profile separates what is known from source-linked evidence, what remains uncertain, safety considerations, and the US regulatory context.

Product category
FDA-approved peptide drug or regulated peptide/hormone medication
Evidence grade
A
Safety level
5/5

3 claims · 1 studies · 6 sources

Open profile

Anidulafungin

Fda Label

Approved

Anidulafungin is classified as Echinocandin lipopeptide antifungal. This starter profile separates broad identity, likely use context, safety caution, and source-review needs.

Product category
FDA-approved or regulated peptide/peptide-derived medication context
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 4 sources

Open profile

Bacitracin

Fda Label

Approved

Bacitracin is classified as Cyclic peptide antibiotic mixture. This starter profile separates broad identity, likely use context, safety caution, and source-review needs.

Product category
FDA-approved or regulated peptide/peptide-derived medication context
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 4 sources

Open profile

Bivalirudin

Fda Label

Angiomax

Approved

Bivalirudin is classified as Direct thrombin inhibitor peptide. This profile separates what is known from source-linked evidence, what remains uncertain, safety considerations, and the US regulatory context.

Product category
FDA-approved peptide drug or regulated peptide/hormone medication
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 6 sources

Open profile

Bremelanotide

Fda Label

PT-141 / Vyleesi

Approved

Bremelanotide is classified as Melanocortin receptor agonist. This profile separates what is known from source-linked evidence, what remains uncertain, safety considerations, and the US regulatory context.

Product category
FDA-approved peptide drug or regulated peptide/hormone medication
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 6 sources

Open profile

Calcitonin salmon

Fda Label

Miacalcin

Approved

Calcitonin salmon is classified as Calcitonin peptide hormone. This profile separates what is known from source-linked evidence, what remains uncertain, safety considerations, and the US regulatory context.

Product category
FDA-approved peptide drug or regulated peptide/hormone medication
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 6 sources

Open profile

Caspofungin

Fda Label

Approved

Caspofungin is classified as Echinocandin lipopeptide antifungal. This starter profile separates broad identity, likely use context, safety caution, and source-review needs.

Product category
FDA-approved or regulated peptide/peptide-derived medication context
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 4 sources

Open profile

Cetrorelix

Fda Label

Cetrotide

Approved

Cetrorelix is classified as GnRH antagonist peptide analog. This profile separates what is known from source-linked evidence, what remains uncertain, safety considerations, and the US regulatory context.

Product category
FDA-approved peptide drug or regulated peptide/hormone medication
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 6 sources

Open profile

Colistin

Fda Label

Approved

Colistin is classified as Polymyxin peptide antibiotic. This starter profile separates broad identity, likely use context, safety caution, and source-review needs.

Product category
FDA-approved or regulated peptide/peptide-derived medication context
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 4 sources

Open profile

Corticorelin

Fda Label

Approved

Corticorelin is classified as Corticotropin-releasing hormone analog. This starter profile separates broad identity, likely use context, safety caution, and source-review needs.

Product category
FDA-approved or regulated peptide/peptide-derived medication context
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 4 sources

Open profile

Cosyntropin

Fda Label

Cortrosyn / Tetracosactide

Approved

Cosyntropin is classified as ACTH analog peptide. This profile separates what is known from source-linked evidence, what remains uncertain, safety considerations, and the US regulatory context.

Product category
FDA-approved peptide drug or regulated peptide/hormone medication
Evidence grade
A
Safety level
4/5

3 claims · 1 studies · 6 sources

Open profile
Regulatory category hubsGoal-based guidesGlossarySafety center